Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Current Rheumatology Reports|September 24, 2009
Intracellular signal pathways: potential for therapiesMelissa Mavers, Eric M Ruderman, Harris PerlmanEuropean Journal of Immunology|February 4, 2009
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophagesJohn C Scatizzi, Melissa Mavers, Jack Hutcheson, et al.Journal of Immunology Research|June 1, 2018
High-Risk Leukemia: Past, Present, and Future Role of NK CellsMelissa Mavers, Alice BertainaCurrent Pharmaceutical Design|February 22, 2005
Current and future pharmaceutical therapy for rheumatoid arthritisEric M RudermanRheumatology (Oxford, England)|December 11, 2012
Overview of safety of non-biologic and biologic DMARDsEric M RudermanJournal of the American Academy of Dermatology|August 2, 2003
Evaluation and management of psoriatic arthritis: the role of biologic therapyEric M RudermanBulletin of the Hospital for Joint Disease (2013)|October 25, 2013
Treating to target in rheumatoid arthritis - challenges and opportunitiesEric M RudermanBulletin of the Hospital for Joint Disease (2013)|November 14, 2013
The role of concomitant methotrexate in biologic therapy for rheumatoid arthritisEric M RudermanThe American Journal of Managed Care|May 7, 2002
Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient careEric M RudermanPageof 19